Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GNPX Genprex, Inc.

盘前交易 11-22 06:14:24 EST

1.14

+0.04

+3.64%

盘前1.17

+0.03+2.63%

05:24 EST

最高1.20	最低1.08	成交量74.90万
今开1.10	昨收1.10	日振幅10.91%
总市值969.92万	流通市值943.94万	总股本850.81万
成交额85.75万	换手率9.05%	流通股本828.02万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GNPX","market":"US","secType":"STK","nameCN":"Genprex, Inc.","latestPrice":1.14,"timestamp":1732222800000,"preClose":1.1,"halted":0,"volume":748972,"hourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.14,"latestTime":"05:24 EST","volume":1,"amount":1.17,"timestamp":1732271086669},"delay":0,"floatShares":8280200,"shares":8508068,"eps":-15.565795,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.04,"latestTime":"11-22 06:14:24 EST","open":1.1,"high":1.2,"low":1.08,"amount":857539.985232,"amplitude":0.109091,"askPrice":1.24,"askSize":100,"bidPrice":1.06,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-15.565795,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732285800000},"adr":0,"listingDate":1522296000000,"adjPreClose":1.14,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.14,"latestTime":"05:24 EST","volume":1,"amount":1.17,"timestamp":1732271086669},"postHourTrading":{"tag":"盘后","latestPrice":1.18,"preClose":1.14,"latestTime":"19:55 EST","volume":9682,"amount":11390.1741,"timestamp":1732236930036},"volumeRatio":0.9180265979928408,"impliedVol":5.668,"impliedVolPercentile":1},"requestUrl":"/m/hq/s/GNPX","defaultTab":"news","newsList":[{"id":"2484675454","title":"Genprex, Inc.盘中异动 早盘快速下挫6.25%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484675454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484675454?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:34","pubTimestamp":1731940455,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时34分，Genprex, Inc.股票出现波动，股价大幅下跌6.25%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为523.49%、228.95%、194.14%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为67.89%、42.57%、34.31%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223415971a7297&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223415971a7297&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2483372922","title":"Genprex, Inc.盘中异动 早盘快速下挫5.49%报1.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372922?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:34","pubTimestamp":1731681243,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时34分，Genprex, Inc.股票出现波动，股价快速下跌5.49%。截至发稿，该股报1.55美元/股，成交量8.6682万股，换手率2.41%，振幅8.54%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为1.37%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522340398e42ed4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522340398e42ed4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2483801463","title":"Genprex, Inc.盘中异动 股价大涨5.62%报1.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483801463","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483801463?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:30","pubTimestamp":1731594647,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时30分，Genprex, Inc.股票出现波动，股价大幅拉升5.62%。截至发稿，该股报1.69美元/股，成交量4.6657万股，换手率1.30%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223047971a68aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223047971a68aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2483838491","title":"Genprex Inc 预计每股亏损68美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483838491","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483838491?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:46","pubTimestamp":1731512766,"startTime":"0","endTime":"0","summary":"Genprex Inc 预计每股亏损68美分 - 财报前瞻Genprex Inc GNPX.OQ GNPX.O预计在11月15日公布截至2024年12月31日的业绩时，季度收入将不会有任何变化(预计)。LSEG分析师对Genprex Inc的平均预期是每股亏损68美分。华尔街对 Genprex Inc 的 12 个月目标价中位数为 8.75 美元，高于 2.09 美元的最新收盘价。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4S3MK1PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2483588922","title":"Genprex, Inc.盘中异动 快速下跌5.74%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483588922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483588922?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:30","pubTimestamp":1731508226,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时30分，Genprex, Inc.股票出现波动，股价大幅下挫5.74%。截至发稿，该股报1.97美元/股，成交量14.6162万股，换手率4.06%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223026abbddce4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223026abbddce4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2482608328","title":"Genprex, Inc.盘中异动 早盘急速拉升6.72%报1.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482608328","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482608328?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421965,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Genprex, Inc.股票出现波动，股价快速上涨6.72%。截至发稿，该股报1.43美元/股，成交量6.6591万股，换手率1.85%，振幅3.73%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222324595be199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222324595be199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2481832374","title":"Genprex Inc 预计每股亏损1.93美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481832374","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481832374?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:53","pubTimestamp":1731081190,"startTime":"0","endTime":"0","summary":"Genprex Inc 预计每股亏损1.93美元 - 财报前瞻Genprex Inc GNPX.OQ GNPX.O预计在11月12日公布截至2024年9月30日的财报() 时，季度营收将不会有任何变化。LSEG 的分析师平均预计 Genprex Inc 每股亏损 1.93 美元。华尔街对 Genprex Inc 的 12 个月目标价中位数为 8.75 美元，高于其最新收盘价 1.69 美元。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF1SX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNPX"],"gpt_icon":0},{"id":"2481102919","title":"Genprex, Inc.盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102919?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:39","pubTimestamp":1731076767,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时39分，Genprex, Inc.股票出现异动，股价快速跳水5.02%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822392798e417b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822392798e417b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2481182596","title":"Genprex, Inc.盘中异动 早盘股价大涨5.81%报1.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481182596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481182596?lang=zh_cn&edition=full","pubTime":"2024-11-07 22:31","pubTimestamp":1730989875,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日22时31分，Genprex, Inc.股票出现波动，股价大幅拉升5.81%。截至发稿，该股报1.64美元/股，成交量4.313万股，换手率1.20%，振幅0.00%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722311598e412eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110722311598e412eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2481698154","title":"Genprex, Inc.盘中异动 急速下挫5.52%报1.71美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481698154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481698154?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:43","pubTimestamp":1730904189,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时43分，Genprex, Inc.股票出现波动，股价快速下挫5.52%。截至发稿，该股报1.71美元/股，成交量13.0697万股，换手率3.63%，振幅4.97%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622430998e40e60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622430998e40e60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2480363584","title":"Genprex, Inc.盘中异动 早盘急速跳水6.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480363584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480363584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:33","pubTimestamp":1730730806,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时33分，Genprex, Inc.股票出现异动，股价快速下跌6.05%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422332698e4047a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422332698e4047a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":0},{"id":"2480788691","title":"Genprex, Inc.盘中异动 股价大涨6.22%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480788691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480788691?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:38","pubTimestamp":1730468305,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时38分，Genprex, Inc.股票出现异动，股价急速拉升6.22%。截至发稿，该股报2.39美元/股，成交量10.5532万股，换手率2.93%，振幅3.56%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121382598e40000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121382598e40000&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2479080789","title":"Genprex, Inc.盘中异动 早盘股价大涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479080789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479080789?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:30","pubTimestamp":1730381459,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时30分，Genprex, Inc.股票出现异动，股价大幅上涨6.42%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213059971a3844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213059971a3844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":0},{"id":"2479483400","title":"Genprex, Inc.盘中异动 早盘股价大跌8.03%报2.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479483400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479483400?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208747,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Genprex, Inc.股票出现异动，股价大幅跳水8.03%。截至发稿，该股报2.52美元/股，成交量34.802万股，换手率9.67%，振幅4.20%。Genprex, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322795bd820b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921322795bd820b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":1},{"id":"2478485483","title":"Genprex, Inc.盘中异动 早盘急速拉升5.27%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478485483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478485483?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:30","pubTimestamp":1730122255,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时30分，Genprex, Inc.股票出现波动，股价大幅拉升5.27%。截至发稿，该股报2.08美元/股，成交量74.051万股，换手率20.58%，振幅1.01%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213056a1f24c83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028213056a1f24c83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":1},{"id":"2478380919","title":"Genprex, Inc.盘中异动 股价大跌11.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478380919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478380919?lang=zh_cn&edition=full","pubTime":"2024-10-25 21:35","pubTimestamp":1729863301,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日21时35分，Genprex, Inc.股票出现异动，股价大幅跳水11.03%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。Genprex的肿瘤学项目利用其系统性、非病毒的Oncoprex传递系统，该系统使用基于脂质的纳米颗粒以脂质复合体形式封装表达基因的质粒。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521350195bd5937&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102521350195bd5937&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139"],"gpt_icon":1},{"id":"2477637954","title":"阿里拉姆制药涨1.87% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2477637954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477637954?lang=zh_cn&edition=full","pubTime":"2024-10-24 22:01","pubTimestamp":1729778502,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日22时01分，阿里拉姆制药股票出现波动，股价大幅上涨1.87%。截至发稿，该股报300.39美元/股，成交量1.9493万股，换手率0.02%，振幅1.83%。机构评级方面，在所有33家参与评级的机构中，70%的券商给予买入建议，27%的券商给予持有建议，3%的券商给予卖出建议。阿里拉姆制药股票所在的生物技术行业中，整体涨幅为0.63%。阿里拉姆制药公司简介：Alnylam Pharmaceuticals是RNA干扰治疗研究的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102422014298e3e428&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348814723.USD","LU1048596156.SGD","BK4579","LU1823568750.SGD","BK4527","BK4538","ALNY","CNSP","LU1515016050.SGD","LU1046421795.USD","BK4139","BK4122","BK4575","LU1051768304.USD","LU0651946864.USD","LU1152091168.USD","LU0797268264.HKD","BK4558","LU1046422090.SGD","BK4524","LU1688375341.USD","LU2226246903.HKD","BK4534","GNPX","BK4220","LU0067412154.USD","BK4548","BK4533","BK4554","LU0918141705.HKD","LU1282648689.USD","BK4526","BK4585","BK4503","LU0918141887.USD","LU1880383366.USD","LU0052756011.USD","BK4588","BK4504","LU0880133367.SGD","IE00B0JY6N72.USD","BK4531","IE00BFMHRM44.USD","BK4587","BK4581","LU1008478684.HKD","LU1105468828.SGD","LU0251143458.SGD","LU1267930227.SGD","LU0348816934.USD"],"gpt_icon":1},{"id":"2477631187","title":"Sensei Biotherapeutics, Inc.盘中异动 急速跳水5.68%报0.531美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477631187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477631187?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:33","pubTimestamp":1729776836,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时33分，Sensei Biotherapeutics, Inc.股票出现异动，股价快速跳水5.68%。Sensei Biotherapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Dbv Technologies涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为199.63%、99.42%、33.61%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Qualigen Therapeutics, Inc.，振幅分别为45.75%、20.04%、13.79%。Sensei Biotherapeutics, Inc.公司简介：Sensei Biotherapeutics Inc 是一家免疫肿瘤学公司，致力于发现和开发治疗癌症患者的新一代疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241024213357ab70a448&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNSE","CNSP","GNPX","BK4139"],"gpt_icon":1},{"id":"2477363970","title":"Genprex, Inc.盘中异动 股价大跌10.94%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477363970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477363970?lang=zh_cn&edition=full","pubTime":"2024-10-24 21:32","pubTimestamp":1729776755,"startTime":"0","endTime":"0","summary":"北京时间2024年10月24日21时32分，Genprex, Inc.股票出现波动，股价急速跳水10.94%。Genprex, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.、Chromocell Therapeutics Corporation涨幅较大，Qualigen Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Genprex, Inc.较为活跃，换手率分别为197.84%、96.59%、32.12%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Hepion Pharmaceuticals, Inc.，振幅分别为41.04%、20.04%、12.73%。Genprex, Inc.公司简介：Genprex Inc是一家临床阶段的基因治疗公司，专注于为患有癌症和糖尿病的患者开发改变生活的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421323595bd4d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102421323595bd4d8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GNPX"],"gpt_icon":1},{"id":"2477235984","title":"Vtv Therapeutics Inc.盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477235984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477235984?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:26","pubTimestamp":1729607219,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时26分，Vtv Therapeutics Inc.股票出现波动，股价急速上涨5.71%。Vtv Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.88%。Vtv Therapeutics Inc.公司简介：vTv Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发代谢性和炎症性疾病的口服治疗药物，以最小化这些疾病的长期并发症，改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222659971a1a07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022222659971a1a07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GNPX","BK4139","LENZ","VTVT"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.genprex.com","stockEarnings":[{"period":"1week","weight":-0.3049},{"period":"1month","weight":-0.6825},{"period":"3month","weight":0.5971},{"period":"6month","weight":-0.4818},{"period":"1year","weight":-0.8897},{"period":"ytd","weight":-0.8761}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Genprex, Inc.于2009年4月在特拉华州注册成立。该公司是一家私人持有的临床阶段生物制药公司，为癌症开发免疫原性治疗。Genprex是一种临床阶段的基因治疗公司，开发一种新的方法来治疗癌症，根据其新的专利技术平台，包括其最初的候选产品，Oncoprex免疫基因治疗提供，或Oncoprex。他们的平台技术旨在通过将其包封在称为纳米囊泡的纳米尺度空心球体中来治疗癌症基因，然后静脉内施用并被肿瘤细胞摄取，其中它们表达缺少或发现量低的蛋白质。 Oncoprex具有多模式作用机制，其中断细胞信号通路，其引起癌细胞的复制和增殖，重新建立癌细胞中凋亡途径或程序性细胞死亡途径，并调节针对癌细胞的免疫应答。 Oncoprex也被证明可以阻断产生耐药性的机制。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.912357},{"month":2,"riseRate":0.5,"avgChangeRate":0.15537},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.179543},{"month":4,"riseRate":0.285714,"avgChangeRate":0.230015},{"month":5,"riseRate":0.428571,"avgChangeRate":0.02727},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.121366},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.165011},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.112826},{"month":9,"riseRate":0,"avgChangeRate":-0.190311},{"month":10,"riseRate":0.142857,"avgChangeRate":0.561276},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.188953},{"month":12,"riseRate":0.5,"avgChangeRate":0.020272}],"exchange":"NASDAQ","name":"Genprex, Inc.","nameEN":"Genprex, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Genprex, Inc.,GNPX,Genprex, Inc.股票,Genprex, Inc.股票老虎,Genprex, Inc.股票老虎国际,Genprex, Inc.行情,Genprex, Inc.股票行情,Genprex, Inc.股价,Genprex, Inc.股市,Genprex, Inc.股票价格,Genprex, Inc.股票交易,Genprex, Inc.股票购买,Genprex, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Genprex, Inc.(GNPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Genprex, Inc.(GNPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}